Cutera, Inc. (NASDAQ:CUTR) EVP Larry Laber sold 5,843 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $45.35, for a total transaction of $264,980.05. Following the sale, the executive vice president now owns 79,463 shares of the company’s stock, valued at $3,603,647.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Larry Laber also recently made the following trade(s):
- On Wednesday, November 15th, Larry Laber sold 1,250 shares of Cutera stock. The shares were sold at an average price of $44.30, for a total transaction of $55,375.00.
- On Wednesday, November 8th, Larry Laber sold 1,700 shares of Cutera stock. The shares were sold at an average price of $42.15, for a total transaction of $71,655.00.
- On Monday, November 6th, Larry Laber sold 500 shares of Cutera stock. The shares were sold at an average price of $41.50, for a total transaction of $20,750.00.
- On Monday, October 16th, Larry Laber sold 500 shares of Cutera stock. The shares were sold at an average price of $40.50, for a total transaction of $20,250.00.
Shares of Cutera, Inc. (CUTR) opened at $44.35 on Friday. The firm has a market cap of $613.08, a PE ratio of 56.86, a PEG ratio of 1.32 and a beta of 0.52. Cutera, Inc. has a 1-year low of $17.48 and a 1-year high of $48.95.
Institutional investors have recently bought and sold shares of the company. Parallel Advisors LLC purchased a new stake in shares of Cutera during the third quarter worth about $117,000. Legal & General Group Plc boosted its holdings in shares of Cutera by 69.6% during the third quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock worth $149,000 after purchasing an additional 1,477 shares during the period. Nationwide Fund Advisors lifted its holdings in Cutera by 8.4% in the second quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock worth $187,000 after buying an additional 561 shares during the period. Greenwood Capital Associates LLC purchased a new stake in Cutera in the third quarter worth about $210,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in Cutera in the second quarter worth about $225,000. Institutional investors own 87.64% of the company’s stock.
CUTR has been the subject of several analyst reports. Roth Capital upped their price target on shares of Cutera from $41.00 to $47.00 and gave the company a “buy” rating in a research report on Tuesday, September 12th. Zacks Investment Research lowered shares of Cutera from a “hold” rating to a “sell” rating in a report on Tuesday, December 26th. Maxim Group lowered shares of Cutera from a “buy” rating to a “hold” rating in a report on Thursday, September 14th. Finally, BidaskClub upgraded shares of Cutera from a “hold” rating to a “buy” rating in a report on Tuesday, December 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. Cutera presently has a consensus rating of “Buy” and a consensus target price of $37.33.
TRADEMARK VIOLATION NOTICE: “Larry Laber Sells 5,843 Shares of Cutera, Inc. (CUTR) Stock” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://sportsperspectives.com/2018/01/06/larry-laber-sells-5843-shares-of-cutera-inc-cutr-stock.html.
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.